Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Calcium antagonists and the kidney

C J Pearce1, J D Wallin

  • 1Section of Nephrology, Louisiana State University School of Medicine, New Orleans 70112, USA.

New Horizons (Baltimore, Md.)
|February 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A non-randomised pilot study of the Solutions for Medication Adherence Problems (S-MAP) intervention in community pharmacies to support older adults adhere to multiple medications.

Pilot and feasibility studies·2021
Same author

Recent developments in equine dentistry.

New Zealand veterinary journal·2020
Same author

Fungal Planet description sheets: 785-867.

Persoonia·2019
Same author

Endoscopic-assisted local intralesional curettage and excision of intraosseous lesions in the talus.

Annals of the Royal College of Surgeons of England·2017
Same author

'New to me': changing patient understanding of psoriasis and identifying mechanisms of change. The Pso Well<sup>®</sup> patient materials mixed-methods feasibility study.

The British journal of dermatology·2017
Same author

Verticillin A Inhibits Leiomyosarcoma and Malignant Peripheral Nerve Sheath Tumor Growth via Induction of Apoptosis.

Clinical & experimental pharmacology·2017

Calcium antagonists, used for cardiovascular conditions, show promise in protecting kidneys. These drugs may slow chronic kidney disease progression by improving renal function and reducing damage.

Area of Science:

  • Cardiovascular Pharmacology
  • Nephrology
  • Renal Physiology

Background:

  • Calcium antagonists are established cardiovascular therapeutics for hypertension, angina, and arrhythmias.
  • Emerging research highlights their significant role in modulating renal functions and protecting against kidney damage.

Purpose of the Study:

  • To explore the renal protective effects of calcium antagonists.
  • To investigate their potential in ameliorating chronic kidney disease progression.

Main Methods:

  • Review of existing investigations and clinical trials on calcium antagonists and renal function.
  • Analysis of their effects on renal hemodynamics, natriuresis, and cellular mechanisms within the kidney.

Main Results:

Related Experiment Videos

  • Calcium antagonists exhibit natriuretic properties, potentially benefiting salt-sensitive hypertension.
  • They block vasoconstriction in afferent arterioles, counteracting nephrotoxic agents like radiocontrast and cyclosporine A.
  • Studies demonstrate their ability to slow chronic renal disease progression through various mechanisms, including preventing glomerular hypertrophy and reducing calcium deposition.

Conclusions:

  • Calcium antagonists offer potential therapeutic benefits beyond cardiovascular conditions, particularly in renal protection.
  • Their multifaceted actions suggest a role in managing and slowing the progression of chronic kidney disease.